Working… Menu
Trial record 1 of 1 for:    YH003002
Previous Study | Return to List | Next Study

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04481009
Recruitment Status : Recruiting
First Posted : July 22, 2020
Last Update Posted : August 13, 2021
Information provided by (Responsible Party):
Eucure (Beijing) Biopharma Co., Ltd

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2022
Estimated Study Completion Date : March 2023